🔓
Sign in as a Member to unlock the full view of HR.7482. · Full carveout list, all affected companies, party defectors, and 30-day trade predictions.
Become a Member$24.50/mo already a Member? Sign in →
HR.7482 · 119TH CONGRESS

LymeX Authorization Act

Status
In Committee
Latest Action
2026-02-11
Sponsor
Smith, Christopher H. (R-New Jersey)
Official Source
Investability
0/100
Stage
COMMITTEE
Related Bills
0
Full Text
1,520 chars
Alive
Yes

What This Bill Does · Plain English

GovGreed Synthesis · AI extraction
This bill authorizes $5 million in funding for the Secretary of Health and Human Services to run prize competitions aimed at spurring innovation in Lyme disease prevention, diagnosis, and treatment.

Carveouts & Earmarks · 2 line items · $5M tagged

Specific dollar amounts in this bill that flow to identifiable companies or programs — the actual cash trail.

$5M
Sec.3
"There is authorized to be appropriated to the Secretary of Health and Human Services $5,000,000 to carry out prize competitions (as defined in section 24 of the Stevenson-Wydler Technology Innovation Act of 1980 ( 15 U.S.C. 3719 )) to accelerate innovation in the prevention, diagnosis, and treatment of Lyme disease."
→ Secretary of Health and Human Services
Sec.2
"engage stakeholders, including academia, nonprofits, industry, small business, entrepreneurs, and government to facilitate patient-centered innovations in Lyme disease care;"
→ Secretary of Health and Human Services

Action Timeline

2026-02-11
Referred to the House Committee on Energy and Commerce.
2026-02-11
Introduced in House
2026-02-11
Introduced in House

Frequently Asked Questions

Did HR.7482 pass?
HR.7482 is still alive. Current stage: COMMITTEE. Pass likelihood: pending.
What does HR.7482 do?
This bill authorizes $5 million in funding for the Secretary of Health and Human Services to run prize competitions aimed at spurring innovation in Lyme disease prevention, diagnosis, and treatment.
Who sponsored HR.7482?
HR.7482 was sponsored by Christopher H. Smith (R-New Jersey).
How much money does HR.7482 spend?
HR.7482 contains $5M in identified line-item carveouts to specific programs and companies, across 2 earmarks.

Full Bill Text

119 HR 7482 IH: LymeX Authorization Act U.S. House of Representatives 2026-02-11 text/xml EN Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain. I 119th CONGRESS 2d Session H. R. 7482 IN THE HOUSE OF REPRESENTATIVES February 11, 2026 Mr. Smith of New Jersey (for himself and Mr. Doggett ) introduced the following bill; which was referred to the Committee on Energy and Commerce A BILL To authorize the Secretary of Health and Human Services to fund prize competitions to accelerate innovation in the prevention, diagnosis, and treatment of Lyme disease, and for other purposes. 1. Short title This Act may be cited as the LymeX Authorization Act . 2. Policy It is the policy of the United States to— (1) engage stakeholders, including academia, nonprofits, industry, small business, entrepreneurs, and government to facilitate patient-centered innovations in Lyme disease care; (2) foster breakthroughs in health education and public awareness initiatives focused on Lyme disease patients; and (3) accelerate development of next-gen diagnostics that are rapid and patient focused. 3. Authorization of appropriations There is authorized to be appropriated to the Secretary of Health and Human Services $5,000,000 to carry out prize competitions (as defined in section 24 of the Stevenson-Wydler Technology Innovation Act of 1980 ( 15 U.S.C. 3719 )) to accelerate innovation in the prevention, diagnosis, and treatment of Lyme disease.
🔒 GovGreed Pro · Trading Intelligence on HR.7482 Get Access — $24.50/mo
Loading intelligence layer…
Bill text sourced from GovInfo.gov · public domain · last updated 2026-09-14. Plain-English summary, score breakdown, and trading-intelligence panels are GovGreed-original analysis derived from STOCK Act filings, SEC Form 4 disclosures, FEC contributions, and Senate LDA lobbying reports — all publicly filed federal records. GovGreed is not affiliated with the U.S. Government. Not financial advice. [live render]